Aurora-A interacts with Cyclin B1 and enhances its stability

Cancer Letters

Volumn 275, Issue 1, 2009, Pages 77-85

  Qin, Lili ^a,b   Tong, Tong ^a   Song, Yongmei ^a   Xue, Liyan ^a   Fan, Feiyue ^b   Zhan, Qimin ^a  

^a CANCER HOSPITAL   (China)

^b INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Aurora A; Carcinogenesis; Cell cycle; Cyclin B1; Protein stability

Indexed keywords

APC PROTEIN; AURORA A KINASE; CYCLIN B1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA INTERFERENCE; UBIQUITINATION; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN B; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; UBIQUITIN;

EID: 58549092767     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.011     Document Type: Article

References (46)

1. Ferrari S. Protein kinases controlling the onset of mitosis. Cell. Mol. Life Sci. 63 (2006) 781-795
2. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2 (2001) 21-32
3. Marumoto T., Zhang D., and Saya H. Aurora-A-a guardian of poles. Nat. Rev. Cancer 5 (2005) 42-50
4. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., and Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20 (1998) 189-193
5. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., Chan C.S., Novotny M., Slamon D.J., and Plowman G.D. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17 (1998) 3052-3065
6. Meraldi P., Honda R., and Nigg E.A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 21 (2002) 483-492
7. Wang X., Zhou Y.X., Qiao W., Tominaga Y., Ouchi M., Ouchi T., and Deng C.X. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25 (2006) 7148-7158
8. Marumoto T., Hirota T., Morisaki T., Kunitoku N., Zhang D., Ichikawa Y., Sasayama T., Kuninaka S., Mimori T., Tamaki N., Kimura M., Okano Y., and Saya H. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells 7 (2002) 1173-1182
9. Jiang Y., Zhang Y., Lees E., and Seghezzi W. AuroraA overexpression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer. Oncogene 22 (2003) 8293-8301
10. Anand S., Penrhyn-Lowe S., and Venkitaraman A.R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3 (2003) 51-62
11. Warner S.L., Bearss D.J., Han H., and Von Hoff D.D. Targeting Aurora-2 kinase in cancer. Mol. Cancer Ther. 2 (2003) 589-595
12. Wang X.X., Liu R., Jin S.Q., Fan F.Y., and Zhan Q.M. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res. 16 (2006) 356-366
13. Evans T., Rosenthal E.T., Youngblom J., Distel D., and Hunt T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33 (1983) 389-396
14. Murray A.W., Solomon M.J., and Kirschner M.W. The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 339 (1989) 280-286
15. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 344 (1990) 503-508
16. King R.W., Deshaies R.J., Peters J.M., and Kirschner M.W. How proteolysis drives the cell cycle. Science 274 (1996) 1652-1659
17. Glotzer M., Murray A.W., and Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature 349 (1991) 132-138
18. Clute P., and Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol. 1 (1999) 82-87
19. Zachariae W., and Nasmyth K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev. 13 (1999) 2039-2058
20. Wolf F., Wandke C., Isenberg N., and Geley S. Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. EMBO J. 25 (2006) 2802-2813
21. Kaufmann W.K., Levedakou E.N., Grady H.L., Paules R.S., and Stein G.H. Attenuation of G2 checkpoint function precedes human cell immortalization. Cancer Res. 55 (1995) 7-11
22. Roh M., Song C., Kim J., and Abdulkadir S.A. Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1. J. Biol. Chem. 280 (2005) 40568-40577
23. Song Y., Zhao C., Dong L., Fu M., Xue L., Huang Z., Tong T., Zhou Z., Chen A., Yang Z., Lu N., and Zhan Q. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis 29 (2008) 307-315
24. Soria J.C., Jang S.J., Khuri F.R., Hassan K., Liu D., Hong W.K., and Mao L. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 60 (2000) 4000-4004
25. Yu M., Zhan Q., and Finn O.J. Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53. Mol. Immunol. 38 (2002) 981-987
26. Takeno S., Noguchi T., Kikuchi R., Uchida Y., Yokoyama S., and Muller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94 (2002) 2874-2881
27. Murakami H., Furihata M., Ohtsuki Y., and Ogoshi S. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch. 434 (1999) 153-158
28. Nozoe T., Korenaga D., Kabashima A., Ohga T., Saeki H., and Sugimachi K. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin. Cancer Res. 8 (2002) 817-822
29. Castro A., Bernis C., Vigneron S., Labbe J.C., and Lorca T. The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene 24 (2005) 314-325
30. Peters J.M. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9 (2002) 931-943
31. Fry A.M., and Yamano H. APC/C-mediated degradation in early mitosis: how to avoid spindle assembly checkpoint inhibition. Cell Cycle 5 (2006) 1487-1491
32. Harper J.W., Burton J.L., and Solomon M.J. The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev. 16 (2002) 2179-2206
33. Eytan E., Moshe Y., Braunstein I., and Hershko A. Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding. Proc. Natl. Acad. Sci. USA 103 (2006) 2081-2086
34. Rape M., Reddy S.K., and Kirschner M.W. The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124 (2006) 89-103
35. de Gramont A., Ganier O., and Cohen-Fix O. Before and after the spindle assembly checkpoint-an APC/C point of view. Cell Cycle 5 (2006) 2168-2171
36. Kramer E.R., Scheuringer N., Podtelejnikov A.V., Mann M., and Peters J.M. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol. Biol. Cell 11 (2000) 1555-1569
37. Shao S., Wang Y., Jin S., Song Y., Wang X., Fan W., Zhao Z., Fu M., Tong T., Dong L., Fan F., Xu N., and Zhan Q. Gadd45a interacts with aurora-A and inhibits its kinase activity. J. Biol. Chem. 281 (2006) 28943-28950
38. Wang Y., and Zhan Q. Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex. J. Biol. Chem. 282 (2007) 17712-17719
39. Ginestier C., Charafe-Jauffret E., Bertucci F., Eisinger F., Geneix J., Bechlian D., Conte N., Adelaide J., Toiron Y., Nguyen C., Viens P., Mozziconacci M.J., Houlgatte R., Birnbaum D., and Jacquemier J. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am. J. Pathol. 161 (2002) 1223-1233
40. Tong T., Zhong Y., Kong J., Dong L., Song Y., Fu M., Liu Z., Wang M., Guo L., Lu S., Wu M., and Zhan Q. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin. Cancer Res. 10 (2004) 7304-7310
41. Cazales M., Schmitt E., Montembault E., Dozier C., Prigent C., and Ducommun B. CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage. Cell Cycle 4 (2005) 1233-1238
42. Roghi C., Giet R., Uzbekov R., Morin N., Chartrain I., Le Guellec R., Couturier A., Doree M., Philippe M., and Prigent C. The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. J. Cell Sci. 111 Pt. 5 (1998) 557-572
43. Jackman M., Lindon C., Nigg E.A., and Pines J. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5 (2003) 143-148
44. Hirota T., Kunitoku N., Sasayama T., Marumoto T., Zhang D., Nitta M., Hatakeyama K., and Saya H. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114 (2003) 585-598
45. Horn V., Thelu J., Garcia A., Albiges-Rizo C., Block M.R., and Viallet J. Functional interaction of Aurora-A and PP2A during mitosis. Mol. Biol. Cell 18 (2007) 1233-1241
46. Yeong F.M., Lim H.H., Padmashree C.G., and Surana U. Exit from mitosis in budding yeast: biphasic inactivation of the Cdc28-Clb2 mitotic kinase and the role of Cdc20. Mol. Cell 5 (2000) 501-511